Effects of the Training of Aerobic Function on Clinical Symptoms and Quality of Life in Patients with Medium and Advanced Lung Cancer

Abstract

Objective. To investigate the effects of the training of aerobic function on clinical symptoms and quality of life in patients with medium and advanced lung cancer. Methods. The study objects were 84 patients with medium and advanced lung cancer who were treated in our hospital (July 2019–July 2021) and their materials were retrospectively reviewed. Depending on the different intervention modes, they were equally divided into control group (routine nursing intervention measures) and experiment group (training of aerobic function), with 42 cases in each group. The clinical symptoms and living quality were compared between the two groups. Results. After intervention, affective meaning, behavior/severity, cognitive/mood, and sensory scores in both groups were decreased, and the various indexes in the experiment group were lower compared with the control group (P < 0.05). After intervention, the patients’ clinical symptoms, such as pain, inappetence, insomnia, and dyspnea in the two groups were improved, and the experiment group achieved eminently better improvement compared with the control group (P < 0.05). After intervention, the walking distances in 6 minute walk test (6MWT) in both groups were increased, and the experiment group achieved observably longer walking distance compared with the control group (P < 0.05). After intervention, the patients’ pulmonary function indexes of forced vital capacity (FVC), forced expiratory volume in 1s (FEV1), and FEV1/FVC% level in the two groups were all improved, and the experiment group had signally better indexes compared with the control group (P < 0.05). After intervention, the patients’ scores of Quality of Life Questionnaire-Core Questionnaire (QLQ-C30) in both groups were decreased, and the experiment group achieved much lower score compared with the control group (P < 0.05). Conclusion. The training of aerobic function has obvious therapeutic effect on medium and advanced lung cancer. This training can mitigate the patients’ cancer-related fatigue and clinical symptoms, improve their pulmonary function, and enhance their athletic ability and quality of life.

Expression of lncRNA LINC00943 in lung squamous cell carcinoma and its relationship with tumor progression

“…LUSC mostly occurs in elderly men who are addicted to smoking and is greatly affected by personal living habits [ 18 , 19 ]. Most patients have no significant symptoms in the early stage, or are accompanied by symptoms such as cough, bloody sputum, chest pain, and fever [ 20 ]. With the gradual deterioration of the disease will appear corresponding respiratory symptoms or cancer metastasis expansion.…”

Quality of Life, Family Support, Spirometry, and 6-Minute Walking Distance Differences between COVID-19 and Non-COVID-19 Intensive Care Unit Patients in One Year Following Hospital Discharge

“…Obviously, in patients with COVID-19, respiratory function is significantly affected during the acute phase, where ICU admission may occur. Previous studies showed that the pulmonary function of patients is compromised [18,28,29] and is marked by reduced lung capacity and volume and respiratory muscle weakness [18,30]; however, there are gradual improvements in FEV1 and FVC [18,[31][32][33], especially following interventions [34]. Hence, the lung functions of surviving patients with acute lung infections are expected to improve and may be normal in the majority of patients [35].…”

Application Value of Evidence-Based Care in Patients with Lung Cancer Chemotherapy

“…LC patients generally present with no obvious early symptoms, resulting in the fact that most of them are diagnosed in the middle and late stages with clinical presentations such as chest pain, hemoptysis, cough, and dyspnea [ 3 ]. Chemotherapy, a common treatment for patients with advanced LC, may also lead to adverse emotions such as irritability, depression, and cancer-related fatigue [ 4 , 5 ], all of which will not only exert varying degrees of negative effects on the self-efficacy and life quality of LC patients undergoing chemotherapy but also reduce patients' treatment compliance that lowers their treatment compliance [ 6 , 7 ]. This puts forward a demand for the management optimization of patients with LC chemotherapy, and exploring an effective and reliable high-quality nursing model is of positive significance for the rehabilitation of such patients [ 8 ].…”